Mirion Technologies Inc

MIR is in a Stage 4 decline characterized by a persistent lower-highs/lower-lows sequence under down-sloping EMAs. The medium-term bias remains bearish, but short-term timing is unfavorable amid extreme oversold conditions. Favor deferred selling (Trim) into the declining EMA cluster to capitalize on potential pullbacks into resistance.

• ↑Q1 orders rose 42% YoY to $288M; management guides 15–20% Q2 growth
• ↑Q1 revenue increased 28% YoY to $258M, driven by nuclear and medical segments
• ↓Negative profitability factors indicate weak returns and poor earnings yield